Cargando…
Novel quinazoline-1,2,3-triazole hybrids with anticancer and MET kinase targeting properties
Oncogenic activation of receptor tyrosine kinases (RTKs) such as MET is associated with cancer initiation and progression. We designed and synthesized a new series of quinazoline derivatives bearing 1,2,3-triazole moiety as targeted anticancer agents. The MET inhibitory effect of synthesized compoun...
Autores principales: | Mortazavi, Motahareh, Eskandari, Masoomeh, Moosavi, Fatemeh, Damghani, Tahereh, Khoshneviszadeh, Mehdi, Pirhadi, Somayeh, Saso, Luciano, Edraki, Najmeh, Firuzi, Omidreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482942/ https://www.ncbi.nlm.nih.gov/pubmed/37673888 http://dx.doi.org/10.1038/s41598-023-41283-2 |
Ejemplares similares
-
Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors
por: Mortazavi, Motahareh, et al.
Publicado: (2022) -
Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met
por: Damghani, Tahereh, et al.
Publicado: (2021) -
Phenanthrotriazine Derivatives Containing Arylidine Hydrazone Moieties as Novel Potential c-Met Inhibitors with Anticancer Effect
por: Edraki, Najmeh, et al.
Publicado: (2021) -
Novel 5-oxo-hexahydroquinoline derivatives: design, synthesis, in vitro P-glycoprotein-mediated multidrug resistance reversal profile and molecular dynamics simulation study
por: Shahraki, Omolbanin, et al.
Publicado: (2017) -
5-Oxo-hexahydroquinoline Derivatives and Their Tetrahydroquinoline Counterparts as Multidrug Resistance Reversal Agents
por: Shahraki, Omolbanin, et al.
Publicado: (2020)